MANAGEMENT OF HYPERTENSION IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 2
Abstract
Diabetes mellitus and hypertension are the most common causes of end-stage renal disease. Blood pressure goals in patients with diabetic kidney disease are <130/80 mmHg. The first line therapy for hypertension in these patients are the angiotensin-converting enzyme inhibitors and/or the angiotensin II receptor blockers. These drugs delay the onset of microalbuminuria, retard progression from microalbuminuria to macroalbuminuria, reduce the urinary albumin-creatinine ratio and improve glomerular filtration rate.
Authors and Affiliations
R. Timar , V. Serban, C. Serafinceanu, A. Vlad, Laura Diaconu, B. Timar, Simona Popescu
Keywords
Related Articles
- EP ID EP155378
- DOI -
- Views 80
- Downloads 0
PREDICTORS OF CHANGES IN PHYSICAL PROPERTIES OF SKIN IN PATIENTS WITH DIABETES MELLITUS
Introduction: The skin, the largest human organ, is often affected by diabetes mellitus (DM). We know that DM affects the hydration of stratum corneum (SC), the sebum content of the skin and to some extent, the bar...
ACUTE PANCREATITIS IN TYPE 2 DIABETES MELLITUS – IMAGING STUDY
The inflammatory diseases of the pancreas represent an important cause of mortality worldwide and in Romania, so that making some clinical and imaging correlations between these disorders and disturbances of the carbohyd...
MONITORING THE PROGRESSION OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY- A PERMANENT CHALLENGE
Aim of study – The monitoring of renal function in 2 statistically comparative groups of patients, first group with diabetic kidney disease (DKD) and the second with non-diabetics patients with the same degree of chronic...
THE ASSOCIATION BETWEEN ADIPONECTIN, LEPTIN, PROINFLAMMATORY MARKERS AND METABOLIC SYNDROME IN OBESE, NONDIABETIC SUBJECTS
The aim of this study was to evaluate the association between adipokines (adiponectin and leptin), inflammatory markers, insulin resistance and metabolic syndrome in obese, non-diabetic subjects. Methods: Thirty three ob...
METABOLIC SYNDROME – THE "SILENT KILLER", A CONTINUING CHALLENGE
Metabolic syndrome, also known as dysmetabolic/plurimetabolic syndrome, X syndrome, insulinresistance syndrome or deadly quartet is an aggregate of interrelated metabolic abnormalities that occur with a higher prevalence...